enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - forløbercellelimfoblastisk leukæmi-lymfom - antineoplastiske midler - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
erwinase 10.000 e pulver til injektions-/infusionsvæske, opløsning
porton biopharma limited - crisantaspase - pulver til injektions-/infusionsvæske, opløsning - 10.000 e
gentacoll 1,3 mg/cm2 implantat
serb s.a. - gentamicinsulfat - implantat - 1,3 mg/cm2
gentamicin "2care4" 1,3 mg/cm2 implantat
2care4 aps - gentamicinsulfat - implantat - 1,3 mg/cm2
implanon implantat
2care4 aps - etonogestrel - implantat
implanon nxt implantat
orifarm a/s - etonogestrel - implantat
leuprorelin "sandoz" 3,6 mg implantat, fyldt injektionssprøjte
sandoz a/s - leuprorelinacetat - implantat, fyldt injektionssprøjte - 3,6 mg
leuprorelin "sandoz" 5 mg implantat, fyldt injektionssprøjte
sandoz a/s - leuprorelinacetat - implantat, fyldt injektionssprøjte - 5 mg
nexplanon 68 mg implantat
n.v. organon - etonogestrel - implantat - 68 mg
nexplanon 68 mg implantat
orifarm a/s - etonogestrel - implantat - 68 mg